Nitric oxide modulates pro- and anti-inflammatory cytokines in lipopolysaccharide-activated macrophages

Journal of Trauma

Volumn 55, Issue 3, 2003, Pages 540-545

  Wu, Chih Hsiung ^a   Chen, Ta Liang ^b   Chen, Tyng Guey ^b   Ho, Wei Pin ^b   Chiu, Wen Ta ^c   Chen, Ruei Ming ^b  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cytokines; Lipopolysaccharide; N Monomethyl arginine; Nitric oxide; Sepsis

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CHEMICAL REACTION; COLORIMETRY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; MACROPHAGE ACTIVATION; MODULATION; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; TRANSLATION REGULATION;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DRUG INTERACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; OMEGA-N-METHYLARGININE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0141633832     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TA.0000033496.62796.3B     Document Type: Article

References (38)

1. Lynn WA, Cohen J. Management of septic shock. J Infect. 1995; 30: 207-212.
2. Tabbutt S. Heart failure in pediatric septic shock: utilizing inotropic support. Crit Care Med. 2001; 29: S231-S236.
3. Raetz CR, Ulevitch RJ, Wright SD, Sibley CH, Ding A, Nathan CF. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J. 1991; 5: 2652-2660.
4. Molloy RG, Mannick JA, Rodrick ML. Cytokines, sepsis and immunomodulation. Br J Surg. 1993; 80: 289-297.
5. West MA, Li MH, Seatter SC, Bubrick MP. Pre-exposure to hypoxia or septic stimuli differentially regulates endotoxin release of tumor necrosis factor, interleukin-6, interleukin-1, prostaglandin E2, nitric oxide, and superoxide by macrophages. J Trauma. 1994; 37: 82-89.
6. Stout RD. Macrophage activation by T cells: cognate and non-cognate signals. Curr Opin Immunol. 1993; 5: 398-403.
7. West MA, Seatter SC, Bellingham J, Clair L. Mechanisms of reprogrammed macrophage endotoxin signal transduction after lipopolysaccharide pretreatment. Surgery. 1995; 118: 220-228.
8. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987; 327: 524-526.
9. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991; 43: 109-142.
10. Chang H, Tsai SY, Chang Y, Chen TL, Chen RM. Therapeutic concentrations of propofol protects mouse macrophages from nitric oxide-induced cell death and apoptosis. Can J Anaesth. 2002; 49: 477-480.
11. Titheradge MA. Nitric oxide in septic shock. Biochim Biophys Acta. 1999; 1411: 437-455.
12. Carswell EA, Old LJ, Kassel RL. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA. 1975; 72: 3666-3670.
13. Beutler B, Cerami A. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature. 1986; 320: 584-588.
14. Oswald IP, Wynn TA, Sher A, James SL. Interleukin-10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor α required as a costimulatory factor for interferon γ-induced activation. Proc Natl Acad Sci USA. 1992; 89: 8676-8680.
15. Nemoto Y, Otsuka T, Niiro H, et al. Differential effects of interleukin-4 and interleukin-10 on nitric oxide production by murine macrophages. Inflamm Res. 1999; 48: 643-650.
16. Drapier JC, Wietzerbin J, Hibbs JB. Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol. 1988; 18: 1587-1592.
17. Corradin SB, Fasel N, Buchmuller-Rouiller Y, Ransijn A, Smith J, Mauel J. Induction of macrophage nitric oxide production by interferon-gamma and tumor necrosis factor-alpha is enhanced by interleukin-10. Eur J Immunol. 1993; 23: 2045-2048.
18. Eigler A, Moeller J, Endres S. Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line Raw 264.7. J Immunol. 1995; 154: 4048-4054.
19. Marcinkiewicz J, Grabowska A, Chain B. Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages. Eur J Immunol. 1995; 25: 947-951.
20. Iuvone T, D'Acquisto F, Carnuccio R, Di Rosa M. Nitric oxide inhibits LPS-induced tumor necrosis factor synthesis in vitro and in vivo. Life Sci. 1996; 59: PL207-PL211.
21. Kuo HP, Wang CH, Huang KS, et al. Nitric oxide modulates interleukin-1β and tumor necrosis factor-α synthesis by alveolar macrophages in pulmonary tuberculosis. Am J Respir Crit Care Med. 2000; 161: 192-199.
22. Chen RM, Lin YL, Jean WC, Chen JS, Wang JH, Liu HC. Nitric oxide induces osteoblast apoptosis through the de novo synthesis of Bax protein. J Orthop Res. 2002; 20: 295-302.
23. Chen RM, Chou MW, Ueng TH. Induction of cytochrome P450 1A1 in human hepatoma HepG2 cells by 6-nitrochrysene. Toxicol Lett. 2000; 117: 69-77.
24. Kirkland TN, Finley F, Leturco D, et al. Analysis of lipopolysaccharide binding by CD14. J Biol Chem. 1993; 268: 24818-24824.
25. Haziot A, Ferrero E, Kontgen F, et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD-14-deficient mice. Immunity. 1996; 4: 407-413.
26. Marin J, Sanchez-Ferrer CF. Role of endothelium-formed nitric oxide on vascular responses. Gen Pharmacol. 1990; 21: 575-587.
27. Leiper J, Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res. 1999; 43: 542-548.
28. Bollag W. Vitamin A and retinoids: from nutrition to pharmacotherapy in dermatology and oncology. Lancet. 1983; 1: 860-863.
29. Motomura K, Sakai H, Isobe H, Nawata H. Effects of retinoids on the production of tumour necrosis factor-alpha and nitric oxide by lipopolysaccharide-stimulated rat Kupffer cells in vitro: evidence for participation of retinoid X receptor signalling pathway. Cell Biochem Funct. 1997; 15: 95-101.
30. Millar CG, Thiemermann C. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition. Br J Pharmacol. 1997; 121: 1824-1830.
31. Bysani GK, Shenep JL, Hildner WK, Stidham GL, Roberson PK. Detoxification of plasma containing lipopolysaccharide by adsorption. Crit Care Med. 1990; 18: 67-71.
32. Saldeeen J. Cytokines induce both necrosis and apoptosis via a common Bcl-2-inhibitable pathway in rat insulin-producing cells. Endocrinology. 2000; 141: 2003-2010.
33. Nolan GP, Ghosh S, Liou HC, Tempst P, Baltimore D. DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide. Cell. 1991; 64: 961-969.
34. Marshall HE, Stamler JS. Exhaled nitric oxide (NO), NO synthase activity, and regulation of nuclear factor (NF)-kappaB. Am J Respir Cell Mol Biol. 1999; 21: 296-297.
35. Yang Z, Zingarelli B, Szabo C. Effect of genetic disruption of poly (ADP-ribose) synthetase on delayed production of inflammatory mediators and delayed necrosis during myocardial ischemia-reperfusion injury. Shock. 2000; 13: 60-66.
36. Molina-Holgado E, Vela JM, Arevalo-Martin A, Guaza C. LPS/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur J Neurosci. 2001; 13: 493-502.
37. Fiorentino DF, Zlotnik A, Vieira P, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 1991; 146: 3444-3451.
38. Haskó G, Szabó C, Németh ZH, Kvetan V, Pastores SM, Vizi S. Adenosine receptor agonists differentially regulate IL-10, TNF-α, and nitric oxide production in Raw 264.7 macrophages and in endotoxemic mice. J Immunol. 1996; 157: 4634-4640.